Filing Details

Accession Number:
0000899243-19-010398
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-09 18:19:15
Reporting Period:
2019-04-05
Accepted Time:
2019-04-09 18:19:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc MYOK Pharmaceutical Preparations (2834) 455500552
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1560168 C. Taylor Harris C/O Myokardia, Inc.
333 Allerton Avenue
South San Francisco CA 94080
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-05 3,750 $0.00 3,750 No 4 M Direct
Common Stock Disposition 2019-04-05 1,324 $53.30 2,426 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2019-04-05 3,750 $0.00 3,750 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,250 No 4 M Direct
Footnotes
  1. Restricted Stock Units ("RSUs") convert into common stock on a one-for-one basis.
  2. The disposition of the shares is solely to cover tax withholding obligations resulting from the vesting of RSUs reported herein.
  3. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The units vest in equal annual installments over 4 years from April 4, 2018, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer.